Xinjiang Bai Hua Cun Pharma Tech Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Xinjiang Bai Hua Cun Pharma Tech Co Ltd

Watchlist Manager

Watchlist

Price: 11.8 CNY -8.24% Market Closed

Market Cap: ¥4.5B

	Xinjiang Bai Hua Cun Pharma Tech Co Ltd SSE:600721	CN
	Brundage-Bone Concrete Pumping Holdings Inc NASDAQ:BBCP	US
	DBS Group Holdings Ltd F:DEVL	SG
	Datagate Bilgisayar Malzemeleri Ticaret AS IST:DGATE.E	TR
	enCore Energy Corp XTSX:EU	CA
	Rohto Pharmaceutical Co Ltd TSE:4527	JP
S	Shape Robotics A/S CSE:SHAPE	DK
W	WSI Co Ltd KOSDAQ:299170	KR
T	Tokyo Gas Co Ltd SWB:TOG	JP
	Veritex Holdings Inc NASDAQ:VBTX	US
	Ouster Inc NASDAQ:OUST	US
	Bionomics Ltd ASX:BNO	AU

Profitability Summary

Xinjiang Bai Hua Cun Pharma Tech Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

42%

Sustainable 3Y Average Gross Margin

45%

Gross Margin is Increasing

41% > 42%

Healthy Operating Margin

11%

Low 3Y Average Operating Margin

Operating Margin is Increasing

-9% > 11%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

-9% > 9%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

10%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.